Long-term risk of incident psoriasis in patients with irritable bowel syndrome: a large-scale prospective cohort study
Journal of Global Health · 07.08.2026 · 16
DOI: 10.7189/jogh.16.04140 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Global Health, online erschienen am 07.08.2026. Verfasst von Yuting Qiu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Psoriasis. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- State Key Laboratory of Digestive Health, Beijing, China.
- National Clinical Research Center for Digestive Disease, Beijing, China.
- Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, Beijing, China.
Zitieren
APA
Qiu, Y., Zhou, Y., Liu, S., Zhang, Q., Zhang, S., Wu, J., Zhu, S., & Wu, S. (2026). Long-term risk of incident psoriasis in patients with irritable bowel syndrome: a large-scale prospective cohort study. Journal of Global Health, 16. https://doi.org/10.7189/jogh.16.04140
Vancouver
Qiu Y, Zhou Y, Liu S, Zhang Q, Zhang S, Wu J, et al. Long-term risk of incident psoriasis in patients with irritable bowel syndrome: a large-scale prospective cohort study. Journal of Global Health. 2026;16. doi:10.7189/jogh.16.04140
BibTeX
@article{Qiu2026,
author = {Qiu, Yuting and Zhou, Yesheng and Liu, Si and Zhang, Qian and Zhang, Shutian and Wu, Jing and Zhu, Shengtao and Wu, Shanshan},
title = {Long-term risk of incident psoriasis in patients with irritable bowel syndrome: a large-scale prospective cohort study},
journal = {Journal of Global Health},
year = {2026},
volume = {16},
doi = {10.7189/jogh.16.04140}
}
EUVIMED